AU698409B2 - Process of high purity albumin production - Google Patents

Process of high purity albumin production

Info

Publication number
AU698409B2
AU698409B2 AU48380/96A AU4838096A AU698409B2 AU 698409 B2 AU698409 B2 AU 698409B2 AU 48380/96 A AU48380/96 A AU 48380/96A AU 4838096 A AU4838096 A AU 4838096A AU 698409 B2 AU698409 B2 AU 698409B2
Authority
AU
Australia
Prior art keywords
albumin
solution
matrix
process according
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU48380/96A
Other languages
English (en)
Other versions
AU4838096A (en
Inventor
Stephen Berezenko
Stephen James Burton
Andrew Robert Goodey
Richard Alan Johnson
Alan Victor Quirk
Darrell Sleep
Hendrik Van Urk
Patricia Carol Wood
John Rodney Woodrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of AU4838096A publication Critical patent/AU4838096A/en
Application granted granted Critical
Publication of AU698409B2 publication Critical patent/AU698409B2/en
Assigned to NOVOZYMES DELTA LIMITED reassignment NOVOZYMES DELTA LIMITED Request to Amend Deed and Register Assignors: DELTA BIOTECHNOLOGY LIMITED
Assigned to NOVOZYMES BIOPHARMA DK A/S reassignment NOVOZYMES BIOPHARMA DK A/S Alteration of Name(s) in Register under S187 Assignors: NOVOZYMES DELTA LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU48380/96A 1995-05-25 1996-02-29 Process of high purity albumin production Ceased AU698409B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US378859 1995-05-25
US08/378,859 US5728553A (en) 1992-09-23 1995-05-25 High purity albumin and method of producing
PCT/GB1996/000449 WO1996037515A1 (en) 1995-05-25 1996-02-29 Process of high purity albumin production

Publications (2)

Publication Number Publication Date
AU4838096A AU4838096A (en) 1996-12-11
AU698409B2 true AU698409B2 (en) 1998-10-29

Family

ID=23494845

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48380/96A Ceased AU698409B2 (en) 1995-05-25 1996-02-29 Process of high purity albumin production

Country Status (15)

Country Link
US (6) US5728553A (enExample)
EP (2) EP1031578B1 (enExample)
JP (4) JP4040088B2 (enExample)
KR (2) KR100543612B1 (enExample)
CN (4) CN1198844C (enExample)
AT (2) ATE265469T1 (enExample)
AU (1) AU698409B2 (enExample)
CA (1) CA2220923C (enExample)
DE (2) DE69611445T2 (enExample)
DK (2) DK0828759T3 (enExample)
ES (2) ES2219257T3 (enExample)
GR (1) GR3035651T3 (enExample)
MX (1) MX9709108A (enExample)
PT (2) PT1031578E (enExample)
WO (1) WO1996037515A1 (enExample)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
DE19538625C2 (de) * 1995-10-17 1999-08-12 Sartorius Gmbh Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
JP4318751B2 (ja) * 1996-03-13 2009-08-26 ノボザイムス、 バイオファーマ、 ユーケー、 リミテッド 発酵制御
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
AU2007200859A1 (en) * 1999-01-30 2007-03-22 Novozymes Delta Limited Process
FR2792650B1 (fr) * 1999-04-20 2003-02-28 Oreal Equivalent de peau agee, son procede de preparation et son utilisation
AU3331501A (en) * 2000-02-08 2001-08-20 Allergan Sales Inc Botulinum toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US8632785B2 (en) 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
EP1278767A4 (en) 2000-04-12 2003-11-12 Principia Pharmaceutical Corp ALBUMIN FUSED PROTEINS
PT1311269E (pt) 2000-08-04 2012-05-10 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composição que contém as mesmas
DE60121196T2 (de) * 2000-10-24 2007-07-12 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Verfahren zur monomerisierung von humanen serumalbumin-polymeren
JP4798832B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
BR0210386A (pt) * 2001-06-13 2004-09-14 Taurus Hsa Llc Purificação de albumina de soro humano
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US20080167238A1 (en) * 2001-12-21 2008-07-10 Human Genome Sciences, Inc. Albumin Fusion Proteins
CA2469435A1 (en) * 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
EP2277889B1 (en) * 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2002364587A1 (en) 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
EP1571970B1 (en) * 2002-10-02 2011-08-17 DMI Biosciences, Inc. Diagnosis and monitoring of diseases
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
KR20120101164A (ko) 2003-05-15 2012-09-12 디엠아이 바이오사이언시스, 인크 Ｔ-세포 매개성 질환의 치료 방법
US8013611B2 (en) * 2006-07-14 2011-09-06 Reserve Power Cell, Llc Vehicle battery product and battery monitoring system
US7339347B2 (en) * 2003-08-11 2008-03-04 Reserve Power Cell, Llc Apparatus and method for reliably supplying electrical energy to an electrical system
GB0329722D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
AU2004313242A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
DK1710250T3 (da) 2004-01-20 2009-07-06 Chemo Sero Therapeut Res Inst Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
WO2006094185A2 (en) * 2005-03-03 2006-09-08 Dmi Biosciences Inc. Quantification of proteins
US7598700B2 (en) * 2005-03-30 2009-10-06 Reserve Power Cell, Llc Tamper resistant battery and battery warranty and performance tracking system
MY144344A (en) * 2005-04-08 2011-09-15 Ciba Holding Inc Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials
DE102005023155A1 (de) 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
US8323666B2 (en) 2005-08-01 2012-12-04 Allergan, Inc. Botulinum toxin compositions
GB0518460D0 (en) * 2005-09-09 2005-10-19 Univ Nottingham Trent Protein assay
AR059300A1 (es) 2006-02-02 2008-03-26 Trimeris Inc Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas
JP2007284425A (ja) * 2006-03-20 2007-11-01 Nokodai Tlo Kk タンパク質の精製方法
BRPI0712383A2 (pt) 2006-06-07 2012-07-10 Human Genome Sciences Inc proteìnas de fusão da albumina
CA2657277C (en) * 2006-07-13 2015-11-24 Upperton Limited Process for preparing particles of proteinaceous material
ATE524493T1 (de) 2006-07-24 2011-09-15 Biorexis Pharmaceutical Corp Exendin-fusionsproteine
US10829733B2 (en) * 2007-01-04 2020-11-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent human stem cells
CA2682848A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics
CN101104635B (zh) * 2007-04-30 2010-11-03 北京济普霖生物技术有限公司 一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法
CN101835801B (zh) * 2007-08-08 2014-09-10 诺维信生物制药丹麦公司 转铁蛋白变体和偶联物
CN101874038A (zh) * 2007-09-25 2010-10-27 特里梅里斯公司 治疗性抗-hiv肽的合成方法
JP4452324B2 (ja) * 2008-03-31 2010-04-21 積水メディカル株式会社 精製血清アルブミン及び免疫学的測定方法
NZ602479A (en) * 2008-05-15 2013-05-31 R Tech Ueno Ltd Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5711118B2 (ja) 2008-06-24 2015-04-30 テクニッシュ ウニヴェルジテート ミュンヘン 所与の標的に対してアフィニティーを有するｈＮＧＡＬおよび類縁タンパク質のムテイン
WO2010092135A2 (en) 2009-02-11 2010-08-19 Novozymes Biopharma Uk Ltd. Albumin variants and conjugates
SG173469A1 (en) 2009-02-20 2011-09-29 Ventria Bioscience Cell culture media containing combinations of proteins
DE102009013914B4 (de) * 2009-03-19 2011-05-05 Bruker Daltonik Gmbh Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
US9403898B2 (en) * 2009-05-07 2016-08-02 Novozymes Biopharma Dk A/S Method for purifying albumin
IN2012DN00407A (enExample) 2009-08-05 2015-08-21 Pieris Ag
WO2011022657A1 (en) * 2009-08-20 2011-02-24 Baxter International Inc. Purification of vwf for increased removal of non-lipid enveloped viruses
EP3421491A3 (en) 2009-10-30 2019-03-27 Albumedix Ltd Albumin variants
RU2707126C2 (ru) 2009-12-07 2019-11-22 Пирис Аг МУТЕИНЫ ЛИПОКАЛИНА 2 ЧЕЛОВЕКА (Lcn2, hNGAL) С АФФИННОСТЬЮ ДЛЯ ОПРЕДЕЛЕННОЙ МИШЕНИ
US20130157356A1 (en) * 2010-01-25 2013-06-20 Ventria Bioscience Methods & compositions for improving protein production
US10233228B2 (en) 2010-04-09 2019-03-19 Albumedix Ltd Albumin derivatives and variants
EP2580236B1 (en) 2010-06-08 2019-04-03 Pieris Pharmaceuticals GmbH Tear lipocalin muteins binding il-4 r alpha
DK2606061T3 (da) 2010-08-16 2017-11-06 Pieris Pharmaceuticals Gmbh Bindingsproteiner til hepcidin
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
US9260492B2 (en) 2010-11-15 2016-02-16 Pieris Ag Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
DK2646552T3 (en) 2010-12-02 2017-10-23 Pieris Pharmaceuticals Gmbh MUTEINES OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR CTLA-4
PL221899B1 (pl) 2011-05-06 2016-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Czysta albumina oraz sposób jej otrzymywania i detekcji
BR112014000042A2 (pt) 2011-07-05 2017-02-21 Novozymes Biopharma Dk As composição, meio de cultura celular, uso de uma composição, e, método para cultivar células
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
MX2014003856A (es) 2011-10-10 2015-01-16 Ampio Pharmaceuticals Inc Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos.
SG11201400283RA (en) 2011-10-28 2014-03-28 Ampio Pharmaceuticals Inc Treatment of rhinitis
HK1200842A1 (en) 2011-11-18 2015-08-14 Albumedix Ltd Proteins with improved half-life and other properties
ES2710384T3 (es) 2011-12-13 2019-04-24 Pieris Pharmaceuticals Gmbh Procedimientos para la prevención o el tratamiento de determinados trastornos mediante la inhibición de la unión de IL-4 y/o IL-13 a sus respectivos receptores
JP6441682B2 (ja) 2012-03-16 2018-12-19 アルブミディクス リミティド アルブミン変種
WO2013174783A1 (en) 2012-05-23 2013-11-28 Pieris Ag Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
US20140031527A1 (en) * 2012-07-27 2014-01-30 Csl Limited Method for polishing albumin
CN105452290A (zh) 2012-11-08 2016-03-30 诺维信生物制药丹麦公司 白蛋白变体
US10526384B2 (en) 2012-11-19 2020-01-07 Pieris Pharmaceuticals Gmbh Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
US20140186447A1 (en) * 2012-12-28 2014-07-03 Abraxis Bioscience, Llc Nanoparticle compositions of albumin and paclitaxel
JP6128677B2 (ja) * 2013-02-05 2017-05-17 公立大学法人大阪市立大学 神経細胞の遊走障害を伴う疾患の判定方法及びその利用
MX2015012420A (es) 2013-03-14 2016-06-02 Daiichi Sankyo Co Ltd Nuevas proteinas de union para pcsk9.
AU2014232728B2 (en) 2013-03-15 2019-02-21 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN103694343B (zh) * 2013-12-26 2016-05-25 扬州艾迪生物科技有限公司 一种从尿液中制备人血白蛋白的方法
AU2015205530B8 (en) 2014-01-13 2019-09-19 Pieris Pharmaceuticals Gmbh Multi-specific polypeptide useful for localized tumor immunomodulation
CN106459142B (zh) * 2014-04-30 2021-07-13 诺和诺德股份有限公司 使用辛酸纯化蛋白质的方法
ES2823563T3 (es) 2014-05-22 2021-05-07 Pieris Pharmaceuticals Gmbh Polipéptidos de unión específica novedosos y usos de los mismos
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN104628830A (zh) * 2015-01-23 2015-05-20 深圳康泰生物制品股份有限公司 重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗
RU2720688C2 (ru) 2015-01-28 2020-05-12 ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ Новые белки, специфические в отношении ангиогенеза
WO2016131804A1 (en) 2015-02-18 2016-08-25 Sanofi Novel proteins specific for pyoverdine and pyochelin
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
AU2016258952C1 (en) 2015-05-04 2020-12-24 Pieris Pharmaceuticals Gmbh Proteins specific for CD137
MX2017014083A (es) 2015-05-04 2018-11-09 Pieris Pharmaceuticals Gmbh Polipeptido de fusion anti-cancer.
AU2016262838B2 (en) 2015-05-18 2020-10-08 Pieris Pharmaceuticals Gmbh Muteins of human lipocalin 2 with affinity for Glypican-3 (GPC3)
CA2980838A1 (en) 2015-05-18 2016-11-24 Pieris Pharmaceuticals Gmbh Anti-cancer fusion polypeptide
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
EP3115371A1 (en) 2015-07-07 2017-01-11 Sanofi Fusion molecules
AU2016293101B2 (en) 2015-07-15 2022-06-16 Pieris Pharmaceuticals Gmbh Novel proteins specific for LAG-3
BR112018003179A2 (pt) 2015-08-20 2018-09-25 Albumedix As conjugados e variantes de albumina
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique
CA3004918A1 (en) 2015-11-30 2017-06-08 Pieris Australia Pty Ltd. Novel anti-angiogenic fusion polypeptides
TW201725212A (zh) 2015-12-10 2017-07-16 第一三共股份有限公司 特異性於降鈣素基因相關胜肽的新穎蛋白
CA3005953A1 (en) 2015-12-22 2017-06-29 Albumedix Ltd Improved protein expression strains
JP7146637B2 (ja) 2015-12-22 2022-10-04 アルブミディクス リミティド 改善されたタンパク質発現株
KR102050852B1 (ko) * 2016-03-11 2019-12-03 주식회사 스템온 세포 리프로그래밍 장치
WO2018033482A1 (en) * 2016-08-17 2018-02-22 Boehringer Ingelheim International Gmbh Process for the preparation of highly concentrated liquid formulations containing biomolecules
KR102573478B1 (ko) 2016-10-04 2023-09-04 알부메딕스 리미티드 재조합 효모-유래 혈청 알부민의 용도
WO2018087108A1 (en) 2016-11-09 2018-05-17 Pieris Pharmaceuticals Gmbh Proteins specific for cd137
AU2018209178B2 (en) 2017-01-18 2021-07-29 Pieris Pharmaceuticals Gmbh Lipocalin muteins with binding affinity for LAG-3
EP3601331A4 (en) * 2017-03-16 2021-01-20 Evolve Biologics Inc. ALBUMIN PURIFICATION PROCESS
AU2018286919B2 (en) 2017-06-20 2022-10-06 Sartorius Albumedix Limited Improved protein expression strains
IL277797B1 (en) * 2018-04-12 2024-11-01 Amgen Inc Methods for making stable protein compositions
CN110563833A (zh) * 2018-06-06 2019-12-13 中国计量科学研究院 一种人血白蛋白标准物质原料的制备方法及其产品和应用
US20210363257A1 (en) 2018-07-31 2021-11-25 Pieris Pharmaceuticals Gmbh Novel fusion protein specific for cd137 and pd-l1
CN109734796B (zh) * 2019-02-01 2022-04-15 广州蕊特生物科技有限公司 一种从溶血血清中分离白蛋白的工艺
CN109776673B (zh) * 2019-02-20 2022-03-29 天津理工大学 一种适合中试量产的高纯度牛血清白蛋白纯化工艺
CA3124441A1 (en) 2019-02-26 2020-09-03 Pieris Pharmaceuticals Gmbh Novel fusion proteins specific for cd137 and gpc3
CN110229229A (zh) * 2019-07-10 2019-09-13 甘肃养泰和生物科技有限公司 一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用
JP2022553426A (ja) 2019-10-28 2022-12-22 アブラクシス バイオサイエンス， エルエルシー アルブミンおよびラパマイシンの医薬組成物
WO2021245240A1 (en) 2020-06-05 2021-12-09 Pieris Pharmaceuticals Gmbh Multimeric immunomodulator targeting 4-1bb
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
KR20230066354A (ko) * 2020-08-11 2023-05-15 선전 프로트젠 엘티디. ??고 손상되지 않은 인간 혈청 알부민이 인간 수명 연장을 개선
JP2023547479A (ja) * 2020-10-30 2023-11-10 シェンチェン、プロトゲン、リミテッド 疾患の治療におけるヒト血清アルブミンの使用
JP7674630B2 (ja) 2020-12-08 2025-05-12 通化安睿特生物製薬股▲フェン▼有限公司 組換えタンパク質を精製する方法
CN112592399B (zh) * 2020-12-15 2024-04-12 甘肃养泰和生物科技有限公司 一种从牛血清中分离牛血清白蛋白的制备方法及装置
US12151045B2 (en) 2020-12-28 2024-11-26 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
EP4320141A1 (en) 2021-04-08 2024-02-14 Pieris Pharmaceuticals GmbH Novel lipocalin muteins specific for connective tissue growth factor (ctgf)
WO2022243341A1 (en) 2021-05-18 2022-11-24 Pieris Pharmaceuticals Gmbh Lipocalin muteins with binding affinity for ox40
CN113735963A (zh) * 2021-09-10 2021-12-03 山东健通生物科技有限公司 一种重组人血清白蛋白纯化过程去除色素的方法
CN114316088B (zh) * 2021-12-22 2022-09-09 中国水产科学研究院黄海水产研究所 亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用
PE20251544A1 (es) 2022-09-21 2025-06-05 Seagen Inc Nueva proteina de fusion especifica para cd137 y cd228
CN115677848A (zh) 2022-10-24 2023-02-03 通化安睿特生物制药股份有限公司 一种制备高纯度高稳定性蛋白质的方法
CN116120392B (zh) * 2023-04-18 2023-08-01 上海健士拜生物科技有限公司 聚体蛋白的纯化方法
WO2025175123A1 (en) 2024-02-16 2025-08-21 Seagen Inc. Methods of treating cancer using fusion proteins specific for cd137 and cd228

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004367A1 (en) * 1990-09-12 1992-03-19 Delta Biotechnology Limited Separation of proteins and dyes
EP0570916A2 (en) * 1992-05-20 1993-11-24 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2433905A (en) 1943-11-01 1948-01-06 Jr Walter L Hughes Method for the crystallization of albumin and the preparation of protein products therefrom
AT317418B (de) * 1972-06-16 1974-08-25 Brigitte Panhofer Verfahren zur Herstellung von intravenös beim Menschen anwendbarem Humanalbumin aus menschlichen Placenten
FR2190437B1 (enExample) 1972-07-05 1975-08-08 Merieux Inst
CA1044537A (en) 1973-05-09 1978-12-19 Amf Incorporated Filter medium and process
DE2537123A1 (de) * 1975-08-20 1977-03-03 New Zealand Inventions Dev Verfahren zur herstellung von albumin
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4043997A (en) * 1976-05-28 1977-08-23 Cutter Laboratories, Inc. Method for isolating albumin using insoluble supports coupled to a dye
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
IN150740B (enExample) 1978-11-24 1982-12-04 Hoffmann La Roche
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4222934A (en) * 1979-04-12 1980-09-16 American National Red Cross Preparation of albumin using ethanol
GB2053926B (en) 1979-07-20 1983-02-23 Atkinson A Albumin extraction by affinity chromatography
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US4391801A (en) 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
CA1286622C (en) * 1986-04-28 1991-07-23 Chokyun Rha Method for clarifying and stabilizing cell culture media
JPS62294621A (ja) 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法
JPS6383100A (ja) * 1986-09-26 1988-04-13 Green Cross Corp:The ヒト尿中アルブミンの製造方法
US4833233A (en) 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
US4990447A (en) * 1988-06-24 1991-02-05 Gist-Brocades Nv Process for the purification of serum albumin
FR2649991B2 (fr) 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
GB8913586D0 (en) 1989-06-13 1989-08-02 Technicol Limited A method of determining the glycosylated protein level of a sample and an apparatus for use in the method
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
SE500110C2 (sv) 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
CA2022165C (en) 1989-10-05 1999-11-23 Chong E. Chang Albumin purification
ATE269872T1 (de) * 1990-04-19 2004-07-15 Bayer Ag Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JP2982296B2 (ja) 1990-11-19 1999-11-22 吉富製薬株式会社 アルブミン含有水溶液の精製法
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
FR2672604B1 (fr) 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5284777A (en) 1991-03-04 1994-02-08 Isolab, Inc. Combined glycated hemoglobin and immunoturbidometric glycated albumin assay from whole blood lysate
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
DK0524681T3 (da) * 1991-07-12 2000-04-10 Dsm Nv Fremgangsmåde til oprensning af serumalbumin
FR2686620B1 (fr) * 1992-01-27 1995-06-23 Rhone Poulenc Rorer Sa Serum-albumine humaine, preparation et utilisation.
US5281582A (en) * 1992-02-27 1994-01-25 Alliance Pharmaceuticals, Corp. Serum growth factor
JP3360315B2 (ja) * 1992-07-31 2002-12-24 三菱ウェルファーマ株式会社 ヒト血清アルブミンの高度精製方法
DE4226971C2 (de) 1992-08-14 1997-01-16 Widmar Prof Dr Tanner Modifizierte Pilzzellen und Verfahren zur Herstellung rekombinanter Produkte
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CN1055095C (zh) * 1992-12-11 2000-08-02 上海莱士血制品有限公司 白蛋白的纯化方法
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
SE9301583D0 (sv) 1993-05-07 1993-05-07 Kabi Pharmacia Ab Yeast strain and methods for expressing heterologous proteins in yeast
JP3702474B2 (ja) 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
DE69532492T2 (de) * 1994-08-31 2004-12-02 Mitsubishi Pharma Corp. Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
JPH09209303A (ja) 1996-02-05 1997-08-12 Hokkaido Supuritsuton Kogyo Kk 舗装ブロック
WO1997031947A1 (en) 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004367A1 (en) * 1990-09-12 1992-03-19 Delta Biotechnology Limited Separation of proteins and dyes
EP0570916A2 (en) * 1992-05-20 1993-11-24 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same

Also Published As

Publication number Publication date
US20050142636A1 (en) 2005-06-30
ATE198482T1 (de) 2001-01-15
AU4838096A (en) 1996-12-11
US7601515B2 (en) 2009-10-13
CN100455597C (zh) 2009-01-28
DK1031578T3 (da) 2004-06-01
DE69632353D1 (de) 2004-06-03
JP2003048900A (ja) 2003-02-21
CN1198844C (zh) 2005-04-27
US6034221A (en) 2000-03-07
US5728553A (en) 1998-03-17
EP1031578A2 (en) 2000-08-30
JP4372813B2 (ja) 2009-11-25
GR3035651T3 (en) 2001-06-29
MX9709108A (es) 1998-06-30
ES2156991T3 (es) 2001-08-01
CA2220923C (en) 2003-01-07
US20030187226A1 (en) 2003-10-02
CN1191545A (zh) 1998-08-26
PT1031578E (pt) 2004-08-31
CN100443499C (zh) 2008-12-17
JP4372772B2 (ja) 2009-11-25
PT828759E (pt) 2001-05-31
CN100584857C (zh) 2010-01-27
CN1880334A (zh) 2006-12-20
HK1072436A1 (zh) 2005-08-26
JP2006342169A (ja) 2006-12-21
US20080009042A1 (en) 2008-01-10
CN1550504A (zh) 2004-12-01
KR19990021994A (ko) 1999-03-25
EP1031578B1 (en) 2004-04-28
DK0828759T3 (da) 2001-02-26
CN1611513A (zh) 2005-05-04
DE69611445T2 (de) 2001-07-19
KR100566606B1 (ko) 2006-12-01
JP4037174B2 (ja) 2008-01-23
HK1009456A1 (en) 1999-06-04
ATE265469T1 (de) 2004-05-15
EP0828759B1 (en) 2001-01-03
DE69632353T2 (de) 2005-05-04
EP0828759A1 (en) 1998-03-18
US7223561B2 (en) 2007-05-29
WO1996037515A1 (en) 1996-11-28
JP4040088B2 (ja) 2008-01-30
EP1031578A3 (en) 2001-01-17
CA2220923A1 (en) 1996-11-28
ES2219257T3 (es) 2004-12-01
KR20040077917A (ko) 2004-09-07
JP2008037867A (ja) 2008-02-21
US6638740B1 (en) 2003-10-28
DE69611445D1 (de) 2001-02-08
KR100543612B1 (ko) 2006-01-20

Similar Documents

Publication Publication Date Title
AU698409B2 (en) Process of high purity albumin production
US7993877B2 (en) Process for the purification of recombinant albumin
JPH11509525A (ja) 高純度アルブミンの製造方法
WO1997031947A1 (en) High purity albumin production process
AU2007200939B2 (en) Process
HK1009456B (en) Process of high purity albumin production
HK1031734B (en) High purity albumin produced by a multistep process
HK1031734A1 (en) High purity albumin produced by a multistep process
HK1072436B (en) Process of high purity albumin production